Alliance releases 2025 annual report
The Alliance's 2025 Annual Report documents a year of progress in the mission to end colorectal cancer.
In 2025, that meant a relentless push to innovate research, stories of community and courage, expanded efforts in awareness and advocacy, and new processes to deliver better cancer care.
2025 Annual Report
See what your support helped build in 2025.
Thank you for your part in fueling the mission to end this disease.
If you're looking to get involved, click here. To make a donation, click here.
Top resources
Alliance Names Kate Watt Chief Development Officer
Watt’s extensive experience in building fundraising strategies and teams will help advance the Alliance's mission to end the disease.
FDA Clears Way for Colorectal Cancer Clinical Trial Led by Dr. Christopher Lieu
The U.S. Food and Drug Administration has given researchers at the University of Colorado Anschutz Medical Campus permission to begin a clinical trial of CAR T-cell therapy for people with advanced colorectal cancer who have already tried the standard treatments without lasting success.
Alliance Appoints New Members to Board of Directors
Each of the four appointees to the Alliance's Board brings unique professional expertise and a personal commitment to the organization's mission to end colorectal cancer in our lifetime.